Cumberland Pharmaceuticals Inc. Comprehensive Income
Cumberland Pharmaceuticals Inc. (CPIX) reported Comprehensive Income of -$1.07 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-22.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-12-10
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-03-31 was -$1.07M.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-12-31 was -$972.35K.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-09-30 was -$1.97M.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2019-06-30 was -$566.81K.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2017 was -$8.05M.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2016 was -$1.00M, a 249.59% decline from fiscal 2015.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2015 was $671.11K, a 71.59% decline from fiscal 2014.
- Cumberland Pharmaceuticals Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2014 was $2.36M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$1.07M 10-Q · filed 2020-05-22 | -$2.04M derived: sum of 2 quarters · filed 2020-12-10 | -$4.00M derived: sum of 3 quarters · filed 2020-12-10 | -$4.57M derived: sum of 4 quarters · filed 2020-12-10 |
| 2019-12-31 | -$972.35K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$2.94M derived: sum of 2 quarters · filed 2020-12-10 | -$3.51M derived: sum of 3 quarters · filed 2020-12-10 | -$3.55M 8-K · filed 2020-12-10 |
| 2019-09-30 | -$1.97M 10-Q · filed 2019-11-13 | -$2.53M derived: sum of 2 quarters · filed 2019-11-13 | -$2.57M 10-Q · filed 2019-11-13 | -$4.81M derived: sum of 4 quarters · filed 2020-12-10 |
| 2019-06-30 | -$566.81K 10-Q · filed 2019-08-14 | -$607.23K 10-Q · filed 2019-08-14 | -$2.84M derived: sum of 3 quarters · filed 2020-12-10 | -$4.51M derived: sum of 4 quarters · filed 2020-12-10 |
| 2019-03-31 | -$40.42K 10-Q · filed 2020-05-22 | -$2.28M derived: sum of 2 quarters · filed 2020-12-10 | -$3.94M derived: sum of 3 quarters · filed 2020-12-10 | -$4.69M derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-12-31 | -$2.24M derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$3.90M derived: sum of 2 quarters · filed 2020-12-10 | -$4.65M derived: sum of 3 quarters · filed 2020-12-10 | -$7.04M 8-K · filed 2020-12-10 |
| 2018-09-30 | -$1.66M 10-Q · filed 2019-11-13 | -$2.41M derived: sum of 2 quarters · filed 2019-11-13 | -$4.80M 10-Q · filed 2019-11-13 | -$5.62M derived: sum of 4 quarters · filed 2020-03-20 |
| 2018-06-30 | -$745.45K 10-Q · filed 2019-08-14 | -$3.14M 10-Q · filed 2019-08-14 | -$3.96M derived: sum of 3 quarters · filed 2020-03-20 | -$4.72M derived: sum of 4 quarters · filed 2020-03-20 |
| 2018-03-31 | -$2.39M 10-Q · filed 2019-05-15 | -$3.21M derived: sum of 2 quarters · filed 2020-03-20 | -$3.97M derived: sum of 3 quarters · filed 2020-03-20 | -$9.15M derived: sum of 4 quarters · filed 2020-03-20 |
| 2017-12-31 | -$821.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$1.58M derived: sum of 2 quarters · filed 2020-03-20 | -$6.76M derived: sum of 3 quarters · filed 2020-03-20 | -$8.05M 10-K · filed 2020-03-20 |
| 2017-09-30 | -$757.24K 10-Q · filed 2018-11-14 | -$5.93M derived: sum of 2 quarters · filed 2018-11-14 | -$7.23M 10-Q · filed 2018-11-14 | -$8.00M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$5.18M 10-Q · filed 2018-08-14 | -$6.47M 10-Q · filed 2018-08-14 | -$7.24M derived: sum of 3 quarters · filed 2019-03-12 | -$7.15M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | -$1.29M 10-Q · filed 2018-05-09 | -$2.06M derived: sum of 2 quarters · filed 2019-03-12 | -$1.97M derived: sum of 3 quarters · filed 2019-03-12 | -$2.03M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$769.93K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$674.44K derived: sum of 2 quarters · filed 2019-03-12 | -$735.38K derived: sum of 3 quarters · filed 2019-03-12 | -$1.00M 10-K · filed 2019-03-12 |
| 2016-09-30 | $95.49K 10-Q · filed 2017-11-08 | $34.55K derived: sum of 2 quarters · filed 2017-11-08 | -$234.01K 10-Q · filed 2017-11-08 | -$105.41K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | -$60.94K 10-Q · filed 2017-08-09 | -$329.50K 10-Q · filed 2017-08-09 | -$200.90K derived: sum of 3 quarters · filed 2018-03-09 | -$79.20K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | -$268.56K 10-Q · filed 2017-05-15 | -$139.96K derived: sum of 2 quarters · filed 2018-03-09 | -$18.26K derived: sum of 3 quarters · filed 2018-03-09 | $376.04K derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $128.60K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $250.30K derived: sum of 2 quarters · filed 2018-03-09 | $644.60K derived: sum of 3 quarters · filed 2018-03-09 | $671.11K 10-K · filed 2018-03-09 |
| 2015-09-30 | $121.70K 10-Q · filed 2016-11-03 | $516.00K derived: sum of 2 quarters · filed 2016-11-03 | $542.51K 10-Q · filed 2016-11-03 | $1.19M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $394.30K 10-Q · filed 2016-08-05 | $420.81K 10-Q · filed 2016-08-05 | $1.07M derived: sum of 3 quarters · filed 2017-03-13 | $1.80M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $26.51K 10-Q · filed 2016-05-13 | $675.08K derived: sum of 2 quarters · filed 2017-03-13 | $1.40M derived: sum of 3 quarters · filed 2017-03-13 | $2.11M derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | $648.56K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $1.38M derived: sum of 2 quarters · filed 2017-03-13 | $2.09M derived: sum of 3 quarters · filed 2017-03-13 | $2.36M 10-K · filed 2017-03-13 |
| 2014-09-30 | $729.18K 10-Q · filed 2015-11-06 | $1.44M derived: sum of 2 quarters · filed 2015-11-06 | $1.71M 10-Q · filed 2015-11-06 | $202.51K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $709.54K 10-Q · filed 2015-08-07 | $984.72K 10-Q · filed 2015-08-07 | -$526.68K derived: sum of 3 quarters · filed 2016-03-14 | -$1.36M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $275.18K 10-Q · filed 2015-05-15 | -$1.24M derived: sum of 2 quarters · filed 2016-03-14 | -$2.07M derived: sum of 3 quarters · filed 2016-03-14 | -$2.72M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$2.34M derived: sum of 2 quarters · filed 2016-03-14 | -$2.99M derived: sum of 3 quarters · filed 2016-03-14 | -$2.15M 10-K · filed 2016-03-14 |
| 2013-09-30 | -$832.50K 10-Q · filed 2014-11-07 | -$1.48M derived: sum of 2 quarters · filed 2014-11-07 | -$640.02K 10-Q · filed 2014-11-07 | $1.15M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | -$648.85K 10-Q · filed 2014-08-08 | $192.47K 10-Q · filed 2014-08-08 | $1.99M derived: sum of 3 quarters · filed 2015-03-09 | $3.85M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $841.33K 10-Q · filed 2014-05-12 | $2.64M derived: sum of 2 quarters · filed 2015-03-09 | $4.50M derived: sum of 3 quarters · filed 2015-03-09 | $6.23M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $3.66M derived: sum of 2 quarters · filed 2015-03-09 | $5.39M derived: sum of 3 quarters · filed 2015-03-09 | $5.81M 10-K · filed 2015-03-09 |
| 2012-09-30 | $1.86M 10-Q · filed 2013-11-06 | $3.60M derived: sum of 2 quarters · filed 2013-11-06 | $4.01M 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $1.74M 10-Q · filed 2013-08-09 | $2.15M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $413.84K 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $5.63M 10-K · filed 2014-03-11 | |||
| 2010-12-31 | $2.43M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |